Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
SemaThera enters into exclusive research collaboration and licensing agreement with Roche
Tuesday, March 23, 2021SemaThera Inc announced the signing of a multiyear research collaboration and license agreement with Roche The partnership will focus on the development of a promising new class of SemaThera biologics for the treatment of diabetic retinopathy and oth...
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001
Tuesday, March 23, 2021RELIEF THERAPEUTICS Holding AG a biopharmaceutical company with its lead compound RLF aviptadil in advanced clinical development to treat severe COVID patients and Acer Therapeutics Inc a pharmaceutical company focused on the acquisition development...
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava™ for the Treatment of Complicated Intra-abdominal Infections
Monday, March 22, 2021Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia
Indivumed announces expansion into drug development and reports the formation of Ix Therapeutics
Saturday, March 20, 2021Indivumed GmbH Indivumed announced together with Xlife Sciences AG Xlife Sciences the establishment of the Ix Therapeutics GmbH Ix Therapeutics joint venture Indivumans expansion into target cancer discovery and drug development bringing entirely new...
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
Friday, March 19, 2021Pyxis Oncology announced that it has entered into a worldwide license agreement with Pfizer Inc NYSEPFE for the development and commercialization of two antibodydrug conjugate ADC candidates and a license to Pfizers ADC technology platform enabling e...
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs
Friday, March 19, 2021Boston Pharmaceuticals announced today a pioneering threeyear outlicense and option agreement with GlaxoSmithKline PLC LSENYSE GSK Boston Pharmaceuticals will become a preferred GSK partner for select prephase programs This new agreement builds on t...
M2GEN Announces New Collaboration with Merck to Advance Cancer Therapies
Thursday, March 18, 2021MGEN a leading oncologyfocused data and informatics company announced today a significant new fiveyear agreement with Merck known as MSD outside the United States and Canada Under the terms of the agreement MGEN will provide valuable patientconsented...
Valence Discovery to Support Repare Therapeutics on AI-Enabled Drug Discovery in Precision Oncology
Thursday, March 18, 2021Valence Discovery Valence an emerging leader in AIenabled drug design today announced it has entered into a drug discovery agreement with Repare Therapeutics a precision oncology company pioneering synthetic lethality to develop novel therapeutics fo...
WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China
Wednesday, March 17, 2021WuXi Biologics a global company with leading openaccess biologics technology platforms announced that it has entered into an equity agreement with Pfizer China Pfizer to acquire its stateoftheart biologics manufacturing facilities as well as its la...
Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers
Wednesday, March 17, 2021Nurix Therapeutics Inc a biopharmaceutical company developing targeted protein modulation drugs announced that it is part of a collaboration sponsored by Alexs Lemonade Stand Foundation ALSF a leading funder of pediatric cancer research
